JP6669966B2 - Medication adjuvant - Google Patents
Medication adjuvant Download PDFInfo
- Publication number
- JP6669966B2 JP6669966B2 JP2016081988A JP2016081988A JP6669966B2 JP 6669966 B2 JP6669966 B2 JP 6669966B2 JP 2016081988 A JP2016081988 A JP 2016081988A JP 2016081988 A JP2016081988 A JP 2016081988A JP 6669966 B2 JP6669966 B2 JP 6669966B2
- Authority
- JP
- Japan
- Prior art keywords
- chocolate
- medicine
- medication
- viscosity
- mass
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims description 72
- 229940079593 drug Drugs 0.000 title claims description 37
- 239000002671 adjuvant Substances 0.000 title claims description 18
- 244000299461 Theobroma cacao Species 0.000 claims description 62
- 235000019219 chocolate Nutrition 0.000 claims description 54
- 239000008187 granular material Substances 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 22
- 210000000214 mouth Anatomy 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 239000003826 tablet Substances 0.000 claims description 12
- 239000003995 emulsifying agent Substances 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- -1 sucrose unsaturated fatty acid ester Chemical class 0.000 claims description 9
- 235000019868 cocoa butter Nutrition 0.000 claims description 7
- 229940110456 cocoa butter Drugs 0.000 claims description 7
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 claims description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000000787 lecithin Substances 0.000 claims description 5
- 235000010445 lecithin Nutrition 0.000 claims description 5
- 229940067606 lecithin Drugs 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 claims description 4
- 229940066675 ricinoleate Drugs 0.000 claims description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 4
- 239000003925 fat Substances 0.000 description 27
- 235000019197 fats Nutrition 0.000 description 27
- 239000003921 oil Substances 0.000 description 19
- 235000019198 oils Nutrition 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 9
- 235000009470 Theobroma cacao Nutrition 0.000 description 7
- 235000019658 bitter taste Nutrition 0.000 description 7
- 238000002844 melting Methods 0.000 description 7
- 230000008018 melting Effects 0.000 description 7
- YHMDGPZOSGBQRH-UHFFFAOYSA-N PPO Natural products CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC YHMDGPZOSGBQRH-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- SVBWNHOBPFJIRU-UHFFFAOYSA-N 1-O-alpha-D-Glucopyranosyl-D-fructose Natural products OC1C(O)C(O)C(CO)OC1OCC1(O)C(O)C(O)C(O)CO1 SVBWNHOBPFJIRU-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- NMXLJRHBJVMYPD-IPFGBZKGSA-N trehalulose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(O)CO[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NMXLJRHBJVMYPD-IPFGBZKGSA-N 0.000 description 4
- 230000000170 anti-cariogenic effect Effects 0.000 description 3
- 235000019879 cocoa butter substitute Nutrition 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000004083 gastrointestinal agent Substances 0.000 description 3
- 229940127227 gastrointestinal drug Drugs 0.000 description 3
- 235000020278 hot chocolate Nutrition 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000014651 chocolate spreads Nutrition 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000020183 skimmed milk Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000009747 swallowing Effects 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- FDCOHGHEADZEGF-UHFFFAOYSA-N (E)-Glycerol 1,3-dihexadecanoate 2-9-octadecenoate Natural products CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC FDCOHGHEADZEGF-UHFFFAOYSA-N 0.000 description 1
- RBLADLVPSYELCA-UHFFFAOYSA-N (Z)-Glycerol 1,3-dioctadecanoate 2-9-octadecenoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC RBLADLVPSYELCA-UHFFFAOYSA-N 0.000 description 1
- RYNHWWNZNIGDAQ-CDAVXRBQSA-N 1,2-Dioleoyl-3-stearoyl-rac-glycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC RYNHWWNZNIGDAQ-CDAVXRBQSA-N 0.000 description 1
- RBLADLVPSYELCA-IKPAITLHSA-N 1,3-bis(octadecanoyloxy)propan-2-yl (9z)-octadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC RBLADLVPSYELCA-IKPAITLHSA-N 0.000 description 1
- PPTGNVIVNZLPPS-LBXGSASVSA-N 1,3-dioleoyl-2-palmitoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PPTGNVIVNZLPPS-LBXGSASVSA-N 0.000 description 1
- FDCOHGHEADZEGF-QPLCGJKRSA-N 1,3-dipalmitoyl-2-oleoylglycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCC\C=C/CCCCCCCC FDCOHGHEADZEGF-QPLCGJKRSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- YHMDGPZOSGBQRH-QPLCGJKRSA-N 2,3-di(hexadecanoyloxy)propyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC YHMDGPZOSGBQRH-QPLCGJKRSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 101100235626 Caenorhabditis elegans hlb-1 gene Proteins 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- JFISYPWOVQNHLS-UHFFFAOYSA-N OOP Natural products CCCCCCCCC=CCCCCCCCC(=O)OC(COC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC JFISYPWOVQNHLS-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- YFFIQXNTTVSKJC-FVDSYPCUSA-N [2-octadecanoyloxy-3-[(z)-octadec-9-enoyl]oxypropyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC YFFIQXNTTVSKJC-FVDSYPCUSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000021544 chips of chocolate Nutrition 0.000 description 1
- 235000010675 chips/crisps Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 235000011869 dried fruits Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 235000019222 white chocolate Nutrition 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 235000019220 whole milk chocolate Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
本発明は、粉、細粒、顆粒、錠剤、又は液剤からなる薬を混ぜて使用するための、チョコレートからなる服薬補助剤に関する。 TECHNICAL FIELD The present invention relates to a medication adjuvant made of chocolate for mixing and using a medicine made of powder, fine granules, granules, tablets, or liquids.
例えば幼児等の年少者や、嚥下困難者などにおいては、粉、細粒、顆粒、錠剤などからなる薬を水だけで服用することが困難である場合がある。 For example, it may be difficult for a young person such as an infant, a person having difficulty in swallowing, and the like to take a medicine composed of powder, fine granules, granules, tablets, and the like using only water.
このような問題を解決するために、口の中で速やかにその形状が崩れる口腔内速崩壊錠や、半固形又は液状を呈するゼリー状製剤や、服用時に熱湯あるいは水に溶解させて液剤とする用時溶解型の製剤などが知られている。 In order to solve such problems, a rapidly disintegrating tablet in the oral cavity, whose shape quickly collapses in the mouth, a jelly-like preparation exhibiting a semi-solid or liquid state, or a liquid preparation which is dissolved in boiling water or water when taken. Dissolving preparations for use are known.
用時溶解型の製剤の一例として、下記特許文献1には、ココアパウダー、甘味剤、脱脂粉乳及び薬剤を含有する用時溶解型のココア製剤が開示されている。 As an example of a ready-to-use formulation, Patent Document 1 below discloses a ready-to-use cocoa formulation containing cocoa powder, a sweetener, skim milk powder, and a drug.
また、下記特許文献2には、ココアバター代替油脂と、カカオ末、甘味料、乳化剤、および薬物を含有するチョコレート剤が開示されている。 Patent Document 2 below discloses a chocolate agent containing cocoa butter substitute fat and oil, cocoa powder, a sweetener, an emulsifier, and a drug.
更に、下記特許文献3には、HLB10〜16のポリグリセリン脂肪酸エステルとHLB1〜5の乳化剤が添加されている飲用チョコレートにおいて、HLB10〜16のポリグリセリン脂肪酸エステルの含有量が0.1重量%以上2.0重量%未満であり、かつHLB10〜16のポリグリセリン脂肪酸エステルとHLB1〜5の乳化剤の含有量の合計が0.1重量%を越えて2.0重量%以下である飲用チョコレートが開示されている。また、この飲用チョコレートは、小児が医薬品を服用する際に医薬品と一緒に飲む嚥下補助食品として用いてもよいことが記載されている。 Further, Patent Literature 3 below discloses that in a drinking chocolate to which a polyglycerin fatty acid ester of HLB 10 to 16 and an emulsifier of HLB 1 to 5 are added, the content of polyglycerin fatty acid ester of HLB 10 to 16 is 0.1% by weight or more. Disclosed is a drinkable chocolate having a content of less than 2.0% by weight and a total content of the polyglycerin fatty acid ester of HLB10-16 and the emulsifier of HLB1-5 exceeding 0.1% by weight and 2.0% by weight or less. Have been. Further, it is described that this drinking chocolate may be used as a swallowing supplement to be taken together with a medicine when the child takes the medicine.
上記特許文献1に記載されたココア製剤や、上記特許文献2に記載されたチョコレート剤は、医薬品を含有する製剤として提供されるものであるため、医師の処方箋等によって出される通常の医薬品に適用できるものではなく、汎用性に乏しいという問題があった。 The cocoa preparation described in Patent Document 1 and the chocolate preparation described in Patent Document 2 are provided as pharmaceutical-containing preparations, and thus are applied to ordinary pharmaceuticals issued according to a doctor's prescription or the like. There was a problem that it could not be done, and was poor in versatility.
上記特許文献3の飲用チョコレートは、医薬品と一緒に飲むことにより、通常の医薬品にも適用できるが、お湯や牛乳やコップ等を用いて溶かし込む必要があるため、医薬品を手軽に服用できないという問題があった。 The drinking chocolate of Patent Document 3 described above can be applied to ordinary medicines by drinking it together with medicines. However, it is necessary to dissolve the medicines using hot water, milk, a cup, or the like, so that the medicines cannot be taken easily. was there.
したがって、本発明の目的は、粉、細粒、顆粒、錠剤、又は液剤からなる薬を手軽に服用することができるようにした服薬補助剤を提供することにある。 Therefore, an object of the present invention is to provide a medication adjuvant capable of easily taking a medicine comprising powder, fine granules, granules, tablets, or a liquid.
上記目的を達成するため、本発明の服薬補助剤は、10〜40℃の温度範囲において粘度が50〜500ポイズの範囲に納まるチョコレートからなり、粉、細粒、顆粒、錠剤、又は液剤からなる薬を服用する際に併用されるものであることを特徴とする。 In order to achieve the above object, the medication adjuvant of the present invention is made of chocolate having a viscosity within a range of 50 to 500 poise in a temperature range of 10 to 40 ° C., and is made of powder, fine granules, granules, tablets, or liquid preparations. It is characterized in that it is used together when taking medicine.
本発明によれば、10〜40℃の温度範囲において粘度が50〜500ポイズの範囲に納まるチョコレートを用いるので、粉、細粒、顆粒、錠剤、又は液剤からなる薬を混ぜやすくなり、薬を手軽にチョコレートに混ぜて服用することができる。また、薬を服用する前に、予め口腔内にチョコレートを含ませることにより、チョコレートが口腔内で速やかに広がるので、その後に薬を服用してもチョコレートの風味でマスキングすることができる。このように、薬と一緒にチョコレートを食べることによって、苦み等を有する薬であっても、抵抗感なく服用することができる。また、粉、細粒、顆粒、錠剤、又は液剤からなる飲み込みにくい薬であっても、容易に飲み込むことができる。また、幅広い温度範囲で、適度な粘度に保たれるので、季節を問わず、使い易い状態に保つことができる。特に、高い粘度を有する液剤からなる薬においても容易に飲み込みやすい粘度に調整することができる。 According to the present invention, a chocolate having a viscosity within a range of 50 to 500 poise is used in a temperature range of 10 to 40 ° C., so that a powder, fine granules, granules, tablets, or a drug consisting of a liquid agent can be easily mixed, You can easily mix it with chocolate and take it. In addition, by including chocolate in the oral cavity in advance before taking the medicine, the chocolate spreads quickly in the oral cavity, so that even after taking the medicine, it is possible to mask with the flavor of chocolate. Thus, by eating chocolate with a medicine, even a medicine having bitterness and the like can be taken without a feeling of resistance. In addition, it is possible to easily swallow even hard-to-swallow medicines composed of powder, fine granules, granules, tablets, or liquid preparations. Further, since the viscosity is maintained at an appropriate level over a wide temperature range, it can be maintained in an easy-to-use state regardless of the season. In particular, it is possible to adjust the viscosity to be easily swallowed even with a drug comprising a liquid having a high viscosity.
本発明の服薬補助剤においては、薬を服用する際に予め混ぜて摂取されるものであることが好ましい。これによれば、予め混ぜて摂取されることにより、適度な粘性を有するチョコレートに薬が練り込まれて、薬が均一に混合されたチョコレートを容易に作ることができる。 In the medication supplement of the present invention, it is preferable that the medication admixture is taken in advance when taking the medicine. According to this, by mixing and ingesting in advance, the medicine is kneaded into chocolate having an appropriate viscosity, and a chocolate in which the medicine is uniformly mixed can be easily produced.
また、本発明の服薬補助剤においては、薬を服用する際に予め口腔内をマスキングするものであることが好ましい。これによれば、予め口腔内をチョコレートの風味でマスキングすることにより、苦み等を有する薬であっても、抵抗感なく服用することができる。 In addition, in the medication-taking adjuvant of the present invention, it is preferable that the oral cavity is masked before taking the medicine. According to this, by masking the inside of the mouth with the flavor of chocolate in advance, even a medicine having bitterness and the like can be taken without resistance.
本発明の服用補助剤においては、パラチノースを1〜70質量%含むことが好ましい。これによれば、幼児や年少者が利用しても、虫歯になりにくく、また、糖尿病患者などの糖質制限の必要性がある人でも利用しやすくなる。 The dosage aid of the present invention preferably contains palatinose in an amount of 1 to 70% by mass. According to this, even if it is used by infants and young people, it is difficult to cause tooth decay, and it is easy to use even for people who need to limit sugars such as diabetic patients.
また、本発明の服用補助剤においては、チューブ入りであることが好ましい。これによれば、粉、細粒、顆粒、錠剤、又は液剤からなる薬に、チューブから押し出したチョコレートを付与して、容易に練り込むことができる。また、残ったチョコレートは、チューブに蓋をして、保管することができる。 In addition, the dosage aid of the present invention is preferably contained in a tube. According to this, the chocolate extruded from the tube can be applied to a medicine composed of powder, fine granules, granules, tablets, or a liquid, and can be easily kneaded. The remaining chocolate can be stored by covering the tube with a lid.
更に、本発明の服用補助剤においては、レシチン、ポリグリセリン縮合リシノール酸エステル、及びHLBが3以下のショ糖不飽和脂肪酸エステルから選択される1つ以上の乳化剤を0.01〜0.5質量%含むことが好ましい。これによれば、チョコレート中の油脂の分離を抑制して、長期間に亘って、安定した品質を保つことができる。 Furthermore, in the dosage aid of the present invention, 0.01 to 0.5 mass of one or more emulsifiers selected from lecithin, polyglycerin condensed ricinoleate, and sucrose unsaturated fatty acid ester having an HLB of 3 or less. %. According to this, separation of fats and oils in chocolate is suppressed, and stable quality can be maintained for a long period of time.
更にまた、本発明の服用補助剤においては、ココアバターの含有量が10質量%以下であることが好ましい。これによれば、保存中にファットブルーミングが起こりにくくすることができる。 Furthermore, in the dosage aid of the present invention, the content of cocoa butter is preferably 10% by mass or less. According to this, fat blooming can hardly occur during storage.
本発明によれば、人が通常活動する室温においてチョコレートが適度な粘性を有するので、薬を練り込みやすく、薬が均一に混合されたチョコレートを容易に作ることができる。また、薬を服用する前に、予め口腔内にチョコレートを含ませることにより、チョコレートが口腔内で速やかに広がって、口腔内をチョコレートの風味でマスキングすることができる。そして、チョコレートと一緒に薬を服用することによって、苦み等を有する薬であっても、チョコレートでマスキングして、抵抗感なく服用することができる。また、粉、細粒、顆粒、錠剤、又は液剤からなる飲み込みにくい薬であっても、容易に飲み込むことができる。また、人が生活する温度範囲で、適度な粘度に保たれるので、季節を問わず、使い易い状態に保つことができる。 ADVANTAGE OF THE INVENTION According to this invention, since chocolate has moderate viscosity at room temperature in which a person normally works, it is easy to knead the medicine, and it is possible to easily produce chocolate in which the medicine is uniformly mixed. In addition, by injecting chocolate into the oral cavity before taking the medicine, the chocolate can be quickly spread in the oral cavity, and the oral cavity can be masked with the flavor of chocolate. Then, by taking the medicine together with the chocolate, even a medicine having bitterness or the like can be masked with the chocolate and taken without any resistance. In addition, even a hard-to-swallow medicine composed of powder, fine granules, granules, tablets, or liquid preparations can be easily swallowed. In addition, since the viscosity is maintained at an appropriate level in a temperature range in which a person lives, it is possible to maintain an easy-to-use state regardless of the season.
本明細書において、チョコレートとは、規約や法規上の規定によって限定されるものではなく、例えば純チョコレート、チョコレート、準チョコレート、ミルクチョコレート、ホワイトチョコレート、ファットスプレッド、チョコレートスプレッドなどいずれでもよく、カカオマス、ココア、ココアバター、ココアバター代用脂などを原料とする油性物全般を意味するものとする。 In the present specification, chocolate is not limited by the rules and regulations, for example, pure chocolate, chocolate, semi-chocolate, milk chocolate, white chocolate, fat spread, chocolate spread, etc. The term refers to all oily substances made from cocoa, cocoa butter, cocoa butter substitute fat and the like.
チョコレートの原料としては、カカオマス、ココアパウダー、ココアバター、ココアバター代用脂のほか、砂糖、パラチノース、トレハルロース、マルトース、トレハロース、糖アルコール等の糖質、スクラロース、アスパルテーム、アセスルファムカリウム等の高甘味度甘味料、食物繊維、全脂粉乳、脱脂粉乳等の粉乳、ヤシ油、パーム油、パーム核油等の各種油脂、及びこれらの硬化油、分別油、エステル交換油等の油脂類、レシチン、ショ糖脂肪酸エステル、グリセリン脂肪酸エステル等の乳化剤などが挙げられる。 Ingredients for chocolate include cocoa mass, cocoa powder, cocoa butter, cocoa butter substitute fat, sugars such as sugar, palatinose, trehalulose, maltose, trehalose, sugar alcohols, and high-sweetness sweeteners such as sucralose, aspartame, and acesulfame potassium. Ingredients, dietary fiber, whole milk powder, milk powder such as skim milk powder, various oils such as coconut oil, palm oil, palm kernel oil, and hardened oils, fractionated oils, oils such as transesterified oils, lecithin, sucrose Emulsifiers such as fatty acid esters and glycerin fatty acid esters are included.
上記において、特に糖質としては、抗う蝕性の糖類、例えばパラチノース、トレハルロースが好ましい。パラチノースやトレハルロースなどの抗う蝕性の糖類を用いることにより、虫歯になりにくく、糖尿病患者などの糖質制限が必要とされる人でも利用しやすくなる。 In the above, in particular, the carbohydrate is preferably an anti-cariogenic saccharide such as palatinose and trehalulose. By using an anti-cariogenic saccharide such as palatinose or trehalulose, it is difficult to cause dental caries and can be easily used even by a person who needs saccharide restriction such as a diabetic patient.
本発明においては、チョコレート中における、パラチノースやトレハルロースなどの抗う蝕性の糖類の含有量が1〜70質量%であり、砂糖の含有量が1質量%以下であることが好ましく、抗う蝕性の糖類の含有量が10〜50質量%であり、砂糖の含有量が0.5質量%以下であることがより好ましい。 In the present invention, the content of anti-cariogenic saccharides such as palatinose and trehalulose in chocolate is preferably from 1 to 70% by mass, and the content of sugar is preferably 1% by mass or less. More preferably, the saccharide content is 10 to 50% by mass, and the sugar content is 0.5% by mass or less.
また、チョコレート中に、乳化剤として、レシチン、ポリグリセリン縮合リシノール酸エステル、及びHLBが3以下のショ糖不飽和脂肪酸エステルから選択される1つ以上の乳化剤を、0.01〜0.5質量%含有することが好ましく、0.05〜0.25質量%含有することがより好ましい。レシチン、ポリグリセリン縮合リシノール酸エステル、及びHLBが3以下のショ糖不飽和脂肪酸エステルから選択される1つ以上の乳化剤を含有することにより、チョコレート中の油脂の分離を抑制して、長期間に亘って、安定した品質を保つことができる。 In chocolate, one or more emulsifiers selected from lecithin, polyglycerin condensed ricinoleate, and sucrose unsaturated fatty acid ester having an HLB of 3 or less as an emulsifier are contained in an amount of 0.01 to 0.5% by mass. It is preferably contained, more preferably 0.05 to 0.25% by mass. By containing one or more emulsifiers selected from lecithin, polyglycerin condensed ricinoleate, and sucrose unsaturated fatty acid ester having an HLB of 3 or less, the separation of fats and oils in chocolate is suppressed, Throughout this, stable quality can be maintained.
更に、チョコレートは、ココアバターの含有量が10質量%以下であることが好ましく、ココアバターの含有量が7.5質量%以下であることがより好ましい。ココアバターの含有量を上記範囲に設定することにより、保存中にファットブルーミングが起こりにくくすることができる。ココアバターの代わりには、下記粘度特性を有する油脂が使用できる。 Further, the chocolate preferably has a cocoa butter content of 10% by mass or less, and more preferably 7.5% by mass or less. By setting the content of cocoa butter in the above range, fat blooming during storage can be suppressed. Instead of cocoa butter, oils and fats having the following viscosity characteristics can be used.
本発明において、上記チョコレートは、10〜40℃の温度範囲において粘度が50〜500ポイズの範囲に納まるように、好ましくは75〜350ポイズの範囲に納まるように調製される。これによって、10〜40℃の通常の使用環境において、チョコレートの粘度が50〜500ポイズの範囲に納まるので、季節等を問わず、薬をチョコレートに混ぜやすく、使用しやすい。粘度が50ポイズ未満になると、チョコレートがこぼれやすくなり、粘度が500ポイズを超えると、チョコレートが硬くて扱いにくく、薬を練り込む作業がしにくくなる。 In the present invention, the chocolate is prepared so that the viscosity falls within a range of 50 to 500 poise, preferably within a range of 75 to 350 poise in a temperature range of 10 to 40 ° C. Thereby, in a normal use environment of 10 to 40 ° C., the viscosity of the chocolate falls within the range of 50 to 500 poise, so that the medicine can be easily mixed into the chocolate and used regardless of the season or the like. When the viscosity is less than 50 poise, the chocolate is easily spilled, and when the viscosity exceeds 500 poise, the chocolate is hard and difficult to handle, and the kneading operation becomes difficult.
なお、本発明において、チョコレートの粘度は、Rapid Visco Analyser (Perton Instruments)を用い、回転数を80rpmとして測定することができる。 In the present invention, the viscosity of chocolate can be measured using a Rapid Visco Analyzer (Perton Instruments) at a rotation speed of 80 rpm.
チョコレートの粘度を上記のような範囲に調製する方法としては、例えば融点が40℃以上の高融点油脂(例えば飽和脂肪酸が炭素数18以上の油脂やヨウ素価が55以下の油脂)と、融点が10℃以下の低融点油脂(例えばヨウ素価が80以上の油脂)とを配合する、好ましくは前記高融点油脂を0.1〜20%、前記低融点油脂を80〜99.9%配合することによって、上記粘度特性を有する油脂を得ることができる。また換言すれば、融点が10〜40℃の油脂(例えばSOS(1,3−ジステアロイル−2−オレオイル−グリセロール)、SSO(1,2−ジステアロイル−3−オレオイル−グリセロール)、SOO(1−ステアロイル−2,3−ジオレオイル−グリセロール)、POP(1,3−ジパルミトイル−2−オレオイル−グリセロール)、PPO(1,2−ジパルミトイル−3−オレオイル−グリセロール)、POO(1−パルミトイル−2,3−ジオレオイル−グリセロール)など)の配合を低く、例えばSOS、SSO、SOO、POP、PPO、POOの総量が40%以下にすることによって、上記粘度特性を有する油脂を得ることができる。 As a method of adjusting the viscosity of chocolate to the above range, for example, a high melting point fats and oils having a melting point of 40 ° C. or more (eg, a saturated fatty acid having 18 or more carbon atoms or an oil having an iodine value of 55 or less) and a melting point of 10 ° C. or less low melting point fat (e.g., iodine value is 80 or more fat), preferably 0.1 to 20% of the high melting point fat, 80 to 99.9% of the low melting point fat by blending the above viscosity. Fats and oils having characteristics can be obtained. In other words, fats and oils having a melting point of 10 to 40 ° C. (eg, SOS (1,3-distearoyl-2-oleoyl-glycerol), SSO (1,2-distearoyl-3-oleoyl-glycerol), SOO (1-stearoyl-2,3-dioleoyl-glycerol), POP (1,3-dipalmitoyl-2-oleoyl-glycerol), PPO (1,2-dipalmitoyl-3-oleoyl-glycerol), POO ( 1-Palmitoyl-2,3-dioleoyl-glycerol), etc.), for example, by reducing the total amount of SOS, SSO, SOO, POP, PPO, POO to 40% or less, to obtain fats and oils having the above viscosity characteristics. be able to.
なお、本発明のチョコレートの10〜40℃における固体脂含量は、1〜40%であることが好ましく、2〜30%であることがより好ましい。10〜40℃における上記固体脂含量が1%未満では、粘度が低くなりすぎ、上記固体脂含量が40%を超えると、粘度が高くなりすぎて、いずれの場合も、薬との混合がしにくくなる。
The solid fat content of the chocolate of the present invention at 10 to 40 ° C. is preferably 1 to 40 % , more preferably 2 to 30 % . If the solid fat content at 10 to 40 ° C. is less than 1 % , the viscosity is too low, and if the solid fat content is more than 40 % , the viscosity is too high. It becomes difficult.
固体脂含量は、次に示す基準油脂分析試験法によって求めることができる(器具、条件等の詳細はIUPAC2.150に準拠)。
(基準油脂分析試験法)
(1)試料を70℃の恒温槽で加熱し、均一にして試験管に入れ、ゴム栓をする。
(2)試験管に詰めた試料を60.0±0.2℃に30分間保持する。
(3)この試料を0±2℃に移し30分間保持し、更に26.0±0.2℃に移し30分間保持する。
(4)再び0±2℃に移し30分間保持した後、測定温度(T±0.2℃)に30分間保持して、固体脂含量を測定する。
(5)測定温度が多い場合は、最も低い温度で測定後、測定試料を次の測定温度に移し、30分間保持した後、固体脂含量を測定する。以下同様の操作を繰り返す。
(6)上記において、固体脂含量の測定は核磁気共鳴(NMR)を用いて行うことができる。
The solid fat content can be determined by the following standard fat / oil analysis test method (details of equipment, conditions, etc. conform to IUPAC 2.150).
(Standard fat and oil analysis test method)
(1) A sample is heated in a 70 ° C. constant temperature bath, made uniform, placed in a test tube, and sealed with a rubber stopper.
(2) Hold the sample packed in the test tube at 60.0 ± 0.2 ° C. for 30 minutes.
(3) Transfer the sample to 0 ± 2 ° C. and hold for 30 minutes, and then transfer to 26.0 ± 0.2 ° C. and hold for 30 minutes.
(4) The temperature is again shifted to 0 ± 2 ° C. and maintained for 30 minutes, and then maintained at the measurement temperature (T ± 0.2 ° C.) for 30 minutes to measure the solid fat content.
(5) If the measurement temperature is high, measure at the lowest temperature, transfer the measurement sample to the next measurement temperature, hold for 30 minutes, and measure the solid fat content. Hereinafter, the same operation is repeated.
(6) In the above, the measurement of the solid fat content can be performed using nuclear magnetic resonance (NMR).
本発明のチョコレート中には、例えばナッツ類の粉砕物、果汁パウダー、果物凍結乾燥チップ、コーヒーチップ、キャラメル、抹茶、カカオニブ、膨化型スナック食品、ビスケットチップ、キャンディーチップ、チョコレートチップ、ドライフルーツ、マシュマロなどの具材を含有させてもよい。 In the chocolate of the present invention, for example, crushed nuts, juice powder, fruit freeze-dried chips, coffee chips, caramel, matcha, cacao nibs, puffed snack foods, biscuit chips, candy chips, chocolate chips, dried fruits, marshmallows And the like.
また、本発明のチョコレートは、含気の処理を施してもよい。含気により、チョコレート生地が軽くなるので、薬との混合操作がより容易になる。 Further, the chocolate of the present invention may be subjected to an aeration treatment. Since the aeration causes the chocolate dough to be lighter, the mixing operation with the medicine becomes easier.
本発明のチョコレートは、各種の容器や包装材に充填して製品化することができる。例えば開閉可能なキャップを有する広口の容器に入れて、スプーン等ですくって使用することができる。また、開閉可能なパウチ、チューブ状などの容器に充填して、容器から押し出して使用することができる。特にチューブ状の容器に充填した場合には、チューブから手軽に押し出すことができるので、使用しやすい。更に、キャップをすることによって、比較的空気に触れにくい状態で保管できるので、長期保存にも適している。また、ポーションパック容器、小容量パウチ容器、小袋包装のような密封小型容器に充填して、一回ずつ使い切ることもできる。これによれば、計量することなく適量を清潔に使用することができる。 The chocolate of the present invention can be commercialized by being filled in various containers and packaging materials. For example, it can be put in a wide-mouthed container having a cap that can be opened and closed, and used with a spoon or the like. Further, it can be filled in a container such as a pouch or a tube that can be opened and closed, and can be used by being pushed out of the container. In particular, when filled in a tube-shaped container, it can be easily extruded from the tube, so that it is easy to use. Further, since the cap can be stored in a state where it is relatively hard to contact with air, it is suitable for long-term storage. Also, it can be filled in a sealed small container such as a potion pack container, a small-capacity pouch container, or a small bag package, and can be used up once. According to this, an appropriate amount can be used cleanly without weighing.
本発明の服薬補助剤が適用される薬としては、粉、細粒、顆粒、錠剤、又は液状をなすものであれば、特に限定されない。 The medicine to which the dosage aid of the present invention is applied is not particularly limited as long as it is in the form of powder, fine granules, granules, tablets, or liquid.
本発明の服薬補助剤は、薬を服用する際に併用されるものであればその摂取のタイミングは問わないが、薬を服用する際に予め混ぜて摂取されるものであること、あるいは薬を服用する際に予め口腔内をマスキングするものであることがより好ましい。 The dosage aid of the present invention is not limited at any timing as long as it is used in combination when taking the drug, but it is taken in advance when taking the drug, or the drug is taken in advance. It is more preferable to mask the inside of the oral cavity before taking.
図1には、本発明の服薬補助剤の使用方法の一例が示されている。この実施形態の服薬補助剤10は、可撓性のチューブ11にチョコレート12を充填し、キャップ13で封止可能なものとされている。そして、適当な受け板、例えば皿14に、粉、細粒、顆粒、錠剤、又は液剤からなる薬15を載置し、チューブ11からチョコレート12を適当量絞り出し、スプーン16でかき混ぜて、チョコレート12と薬15とを混合する。この混合物を摂取することにより、薬の苦さ等を感じずに、また、粉、細粒、顆粒、錠剤、又は液剤からなる薬であっても、飲み込み易い状態で摂取できる。 FIG. 1 shows an example of a method for using the medication adjuvant of the present invention. The medication supplement 10 of this embodiment is such that a flexible tube 11 is filled with chocolate 12 and can be sealed with a cap 13. Then, a medicine 15 made of powder, fine granules, granules, tablets, or a liquid agent is placed on an appropriate receiving plate, for example, a dish 14, and an appropriate amount of chocolate 12 is squeezed out of the tube 11 and stirred with a spoon 16 to mix the chocolate 12 And medicine 15 are mixed. By ingesting this mixture, it is possible to ingest the medicine without feeling the bitterness of the medicine, and even in the form of a powder, fine granules, granules, tablets, or liquid medicine in a state that is easy to swallow.
以下実施例を挙げて本発明を具体的に説明するが、これらの実施例は本発明の範囲を限定するものではない。 Hereinafter, the present invention will be described specifically with reference to Examples, but these Examples do not limit the scope of the present invention.
<チョコレートの製造>
チョコレート原料の油脂として、下記表1及び図2に示す粘度特性を示す油脂A,B,Cを用いた。
<Manufacture of chocolate>
As fats and oils of chocolate raw materials, fats and oils A, B and C having viscosity characteristics shown in Table 1 and FIG. 2 below were used.
油脂A,B,Cは、具体的には下記構成からなるものである。
油脂A:SOS、SSO、SOO、POP、PPO、POOを約35%含有
油脂B:SOS、SSO、SOO、POP、PPO、POOを約20%含有
油脂C:SOS、SSO、SOO、POP、PPO、POOを約50%含有
上記油脂A,B,Cを用いて、下記表2に示す配合によって、実施例1,2、比較例1のチョコレートを製造した。表中の数字は質量部である。
The fats A, B, and C specifically have the following configurations.
Fat A: Fat containing about 35% of SOS, SSO, SOO, POP, PPO, POO Fat B: Fat containing about 20% of SOS, SSO, SOO, POP, PPO, POO C: SOS, SSO, SOO, POP, PPO And about 50% of POO The chocolates of Examples 1 and 2 and Comparative Example 1 were produced by using the above fats and oils A, B and C according to the formulation shown in Table 2 below. The numbers in the table are parts by mass.
<試験例1>
上記実施例1,2,及び比較例1のチョコレートからなる服薬補助剤5gを皿に出し、粉薬0.1gとスプーンで混合し、服薬補助剤としての使いやすさを評価した。評価は、それぞれのチョコレートについて、40℃と10℃のそれぞれの環境下で行った。この結果を下記表3に示す。
<Test Example 1>
5 g of the medication adjuvant consisting of the chocolates of Examples 1, 2 and Comparative Example 1 were put on a plate, mixed with 0.1 g of powdered medicine with a spoon, and evaluated for ease of use as a medication adjuvant. The evaluation was performed for each chocolate under the respective environments of 40 ° C. and 10 ° C. The results are shown in Table 3 below.
表3に示すように、10〜40℃の温度範囲において粘度が50〜500ポイズの範囲に納まるチョコレートからなる実施例1,2の服薬補助剤は、温度40℃の状態でも、温度10℃の状態でも、粉薬と混ぜやすく、皿に残りにくかった。 As shown in Table 3, the medication adjuvants of Examples 1 and 2 made of chocolate having a viscosity falling within a range of 50 to 500 poise in a temperature range of 10 to 40 ° C have a temperature of 10 ° C even at a temperature of 40 ° C. Even in the state, it was easy to mix with powder and it was hard to remain on the plate.
一方、温度40℃で粘度が40ポイズとなり、温度10℃で粘度が600ポイズとなる比較例1の服薬補助剤は、温度40℃のときは、スプーンからたれやすく、混ぜにくく、皿に残りやすく、温度10のときは、硬く混ぜにくかった。 On the other hand, when the temperature is 40 ° C., the viscosity of the poisoning adjuvant of Comparative Example 1 becomes 40 poise at a temperature of 10 ° C. and the viscosity becomes 600 poise at a temperature of 10 ° C. When the temperature was 10, it was hard to mix.
<試験例2>
上記実施例2のチョコレートからなる服薬補助剤5gを口に入れ口腔内をマスキングした後、粉末胃腸薬を服用し、その後、水を飲んで薬の苦みの感じ方を評価した(実施例2−1)。又は、服薬補助剤を口に入れずに粉末胃腸薬を服用し、その後、水を飲んで薬の苦みの感じ方を評価した(比較例2−1)。評価は、5名のパネラーにより、○…よい、×…悪いの評価基準で行い、全パネラーの平均的な評価によって表示した。この結果を表4に示す。
<Test Example 2>
After taking 5 g of the medication adjuvant consisting of the chocolate of Example 2 into the mouth and masking the inside of the oral cavity, the patient took powdered gastrointestinal medication, and then drank water to evaluate how the drug felt bitter (Example 2). 1). Alternatively, the powdered gastrointestinal drug was taken without taking the medication adjuvant into the mouth, and then the patient was allowed to drink water to evaluate the bitterness of the drug (Comparative Example 2-1). The evaluation was performed by five panelists according to the evaluation criteria of…: good, ×: poor, and displayed by the average evaluation of all panelists. Table 4 shows the results.
表4に示すように、服薬補助剤で予め口腔内をマスキングした実施例2−1では、粉末胃腸薬の苦みを感じにくく、飲みやすかった。一方、服薬補助剤で予め口腔内をマスキングしていない比較例2−1では、粉末胃腸薬の苦みを感じ、飲みにくかった。 As shown in Table 4, in Example 2-1 in which the oral cavity was masked in advance with a medication-supplementing agent, the bitterness of the powdered gastrointestinal drug was not easily felt, and the powder was easy to drink. On the other hand, in Comparative Example 2-1 in which the oral cavity was not previously masked with the medication supplement, bitterness of the powdered gastrointestinal drug was felt and it was difficult to drink.
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015170428 | 2015-08-31 | ||
JP2015170428 | 2015-08-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2017048169A JP2017048169A (en) | 2017-03-09 |
JP6669966B2 true JP6669966B2 (en) | 2020-03-18 |
Family
ID=58278438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016081988A Active JP6669966B2 (en) | 2015-08-31 | 2016-04-15 | Medication adjuvant |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6669966B2 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3257983B2 (en) * | 1997-07-31 | 2002-02-18 | 株式会社龍角散 | Drug swallowing aid drink |
DE102005034043B4 (en) * | 2005-07-18 | 2019-12-12 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Mixture containing L-carnitine and trehalulose and product containing the mixture |
JP2014230490A (en) * | 2013-05-28 | 2014-12-11 | 不二製油株式会社 | Production method of chocolate having heat resistance |
-
2016
- 2016-04-15 JP JP2016081988A patent/JP6669966B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2017048169A (en) | 2017-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2016246583B2 (en) | Multicomponent gummy compositions with soft core | |
DK1669090T3 (en) | Bitterness masking particulate gel | |
WO2013044085A1 (en) | A solid, edible, chewable laxative composition | |
CN102573518A (en) | A xylitol containing comestible product | |
BRPI0613321A2 (en) | drug delivery system for a bioactive powder, chocolate product having a uniform distribution of a bioactive powder comprising the drug delivery system, method for the distribution of bioactive powders, use of a lipid, cocoa product having a uniform distribution of a bioactive powder, method for the manufacture of a chocolate product comprising a bioactive powder, method for improving the bioavailability of a lipophilic bioactive powder, method for minimizing the level of degradation of a bioactive powder, method for incorporating bioactive substances in cocoa products, chocolate in wine product, method for enhancing the absorption of a polyphenol in a human's blood and method for promoting a human's vascular health | |
KR20080077651A (en) | Base material for producing food and fodder | |
CN104363897A (en) | Effervescent dosage form | |
JP2008043217A (en) | Food composition | |
JP2018532702A (en) | Laxative formulation and manufacturing | |
JP6669966B2 (en) | Medication adjuvant | |
JP6427318B2 (en) | Usuma movement promotion baked sweets | |
JP7371147B2 (en) | Oral composition | |
JP4025992B2 (en) | Honey-containing low-calorie free-flowing liquid sweetener composition | |
JP5575734B2 (en) | chocolate | |
CN105211482A (en) | Tasty and refreshing sugar of a kind of agate card sugar-free and preparation method thereof | |
ES2224261T3 (en) | PHARMACEUTICAL COMPOSITION INTENDED FOR AN ADMINISTRATION BY ORAL ROUTE. | |
Kaur et al. | Avaleha Kalpana (medicated semisolid preparation): an synoptic overview | |
JP2016199484A (en) | Additive for oral composition | |
JP6686728B2 (en) | Functional hard candy and method for producing the same | |
JP2848711B2 (en) | Combination confectionery | |
WO2024062820A1 (en) | Gummy candy-containing hard candy | |
US6251176B1 (en) | Alginate flavoring in a powdered form | |
JP2014147299A (en) | Center filled hard candy | |
KR20220150768A (en) | Method for producing jelly containing capsules | |
KR20000054644A (en) | Anti-cavity food composition comprising naxazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A80 | Written request to apply exceptions to lack of novelty of invention |
Free format text: JAPANESE INTERMEDIATE CODE: A80 Effective date: 20160421 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190123 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20190909 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190924 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191120 |
|
RD02 | Notification of acceptance of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7422 Effective date: 20191120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200108 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20200108 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200204 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200210 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6669966 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |